Evidence map›Paper›PMID 39910563›Full record

ArticleParticle and fibre toxicology2025

Modulation of the thiol redox proteome by sugarcane ash-derived silica nanoparticles: insights into chronic kidney disease of unknown etiology.

Arthur D Stem, Cole R Michel, Peter S Harris, Keegan L Rogers, Matthew Gibb, Carlos A Roncal-Jimenez, Richard Reisdorph, Richard J Johnson, James R Roede, Kristofer S Fritz and 1 more

Abstract read
In one paragraph

Article in Particle and fibre toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Arthur D StemDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Campus, Aurora, CO, USA.
Cole R MichelDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Campus, Aurora, CO, USA.
Peter S HarrisDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Campus, Aurora, CO, USA.
Keegan L RogersDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Campus, Aurora, CO, USA.
Matthew GibbDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Campus, Aurora, CO, USA.
Carlos A Roncal-JimenezDivision of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Richard ReisdorphDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Campus, Aurora, CO, USA.
Richard J JohnsonDivision of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
James R RoedeDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Campus, Aurora, CO, USA.
Kristofer S FritzDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Campus, Aurora, CO, USA.
Jared M BrownDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Campus, Aurora, CO, USA. jared.brown@cuanschutz.edu.

Funding

Silica Nephropathy and Chronic Kidney Disease of Unknown EtiologyR01DK125351 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Jared Michael Brown, LEE S NEWMAN · 2020 to 2026
$4.0M
Training in Molecular and Systems ToxicologyT32ES029074 · NIEHS · UNIVERSITY OF COLORADO DENVER · PI Jared Michael Brown · 2019 to 2026
$1.1M
NIDDK NIH HHS DK125351NIDDK NIH HHS R01 DK125351NIEHS NIH HHS T32 ES029074
6 · The paper itself

Abstract

introductionChronic kidney disease of unknown etiology (CKDu) is an epidemic which is increasingly prevalent among agricultural workers and nearby communities, particularly those involved in the harvest of sugarcane. While CKDu is likely multifactorial, occupational exposure to silica nanoparticles (SiNPs), a major constituent within sugarcane ash, has gained increased attention as a potential contributor. SiNPs have high potential for generation of reactive oxygen species (ROS), and their accumulation in kidney could result in oxidative stress induced kidney damage consistent with CKDu pathology.

methodsIn order to characterize the impact of sugarcane ash derived (SAD) SiNPs on human kidney proximal convoluted tubule (PCT) cells and identify potential mechanisms of toxicity, HK-2 cells were exposed to treatments of either pristine, manufactured, 200 nm SiNPs or SAD SiNPs and changes to cellular energy metabolism and redox state were determined. To determine how the cellular redox environment may influence PCT cell function and toxicity, the redox proteome was examined using cysteine-targeted click chemistry proteomics.

resultsPristine, 200 nm SiNPs induced minimal changes to energy metabolism and proteomic profiles in vitro while treatment with SAD SiNPs resulted in mitochondrial membrane hyperpolarization, inhibited mitochondrial respiration, increased reactive oxygen species generation, and redox proteomic trends suggesting activation of aryl hydrocarbon receptor (AHR) and other signaling pathways with known roles in mitochondrial inhibition and CKD progression.

conclusionResults suggest that PCT cell exposure to SAD SiNPs could promote glycolytic and fibrotic shifts consistent with CKDu pathology via oxidative stress-mediated disruption of redox signaling pathways.

Indexed as

Kidney Tubules, ProximalNanoparticlesProteomeRenal Insufficiency, ChronicSaccharumSilicon DioxideSulfhydryl CompoundsCell LineChronic Kidney Diseases of Uncertain EtiologyEnergy MetabolismHumansOxidation-ReductionOxidative StressParticle SizeProteomicsReactive Oxygen SpeciesProteomeReactive Oxygen SpeciesSilicon DioxideSulfhydryl CompoundsAryl hydrocarbon receptorChronic kidney disease of an unknown etiologyCKDuCysteineMitochondriaProteomicsRedoxTGFβThiol

Identifiers

PMID39910563
PMCPMC11800628

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.